Navigation Links
Andrew G. Cuneo Joins Mylan as Vice President of Global Business Development
Date:4/13/2009

PITTSBURGH, April 13 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced the appointment of former Merrill Lynch investment banker Andrew G. Cuneo as vice president of Global Business Development. Cuneo is responsible for coordinating Mylan's global business development and strategic efforts in close alignment with the company's executive leadership team.

Mylan's Vice Chairman and CEO Robert J. Coury said: "Drew brings a wealth of experience in the pharmaceutical, biotechnology and health care sectors. His familiarity with our industry - and in particular with Mylan given his and Merrill Lynch's active role with the company during the past five years - makes him ideally suited to support the company's continued growth."

Cuneo joins Mylan from Merrill Lynch, a financial management and advisory firm, where he worked for more than a decade on strategic advisory and capital markets transactions, primarily in the health care sector. Most recently he served as a director in its Global Healthcare Investment Banking group. He earned a Bachelor of Arts in economics and psychology from Vanderbilt University.

"Mylan has emerged as one of the industry's best run and most progressive pharmaceutical franchises," said Cuneo. "I'm excited to be able to continue participating and to further contribute to the development and execution of its plans for profitable commercial expansion."

Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generics and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's third largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. For more information, please visit www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Andrew Dallas, President of Full Spectrum Software Appointed to Medical Device and Diagnostic Industry Magazine Editorial Advisory Board
2. Cantel Medical Corp. Names Andrew Krakauer as CEO and Announces Other Corporate Appointments
3. CorNova Announces Addition of Andrew T. Jay, D.M.D., M.B.A., to its Board of Directors
4. MVP Health Care is First Upstate New York Based Health Insurer to Agree with Attorney General Andrew Cuomo on Out-Of-Network Provider Payment Reform
5. Elsevier Acquires William Andrew Publishing
6. Amira Pharmaceuticals, Inc. Expands its Scientific Advisory Board and Appoints Dr. Paul Anderson, Professor Jerold Chun and Professor Andrew Tager
7. WellPoint Announces Appointment of Andrew J. Lang as Senior Vice President of Application Development
8. Andrew Weils Integrative Medicine Program Bestows Honors on Chopra Centers Director of Womens Health: Valencia Porter, M.D. receives Integrative Medicine Fellowship
9. HealthTalker Founder and CEO Andrew Levitt to be Featured at 'Health 2.0: User-Generated Healthcare 2008'
10. Cadient Group Appoints Andrew le Blanc as Creative Director
11. Andrew W. Gurman, M.D., Re-Elected to Vice Speaker, AMA House of Delegates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Consumers have taken a more ... placed more emphasis on patient outcomes. ... in the pharmaceutical industry have evolved beyond just ... companies are focusing on becoming more patient-oriented across ... and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology: